Objective: Platelet-rich plasma (PRP) is reported to promote collagen synthesis and cell proliferation as well as enhance cartilage repair. Our previous study revealed that the intracapsular injection of muscle derived stem cells (MDSCs) expressing bone morphogenetic protein 4 (BMP-4) combined with soluble Flt-1 (sFlt1) was effective for repairing articular cartilage (AC) after osteoarthritis (OA) induction. The current study was undertaken to investigate whether PRP could further enhance the therapeutic effect of MDSC therapy for the OA treatment. Methods: MDSCs expressing BMP-4 and sFlt1 were mixed with PRP and injected into the knees of immunodeficient rats with chemically induced OA. Histological assessments were performed 4 and 12 weeks after cell transplantation. Moreover, to elucidate the repair mechanisms, we performed in vitro assays to assess cell proliferation, adhesion, migration and mixed pellet co-culture of MDSCs and OA chondrocytes.
Introduction
Platelet-rich plasma (PRP) is defined as an autologous concentration of platelets in a small volume of plasma which is considered to be a rich source of autologous growth factors 1 . Recently, there has been a great interest in the use of PRP for the treatment of orthopedics-related injuries 2 . PRP contains numerous growth factors and bioactive proteins in the alpha-granules of blood platelets 1,3e6 . It has been reported that PRP can promote angiogenesis, collagen synthesis and cell proliferation, and is capable of positively influencing the healing of tendon, ligament, skeletal muscle, and bone 7, 8 .
In regard to articular cartilage (AC), it has been reported that PRP stimulates porcine chondrocyte proliferation and matrix biosynthesis 9 , as well as having the ability to enhance the chondrogenic differentiation capacity of mesenchymal stem cells (MSCs) in vitro 10 .
Furthermore, some in vivo studies also showed that chondrocyte/ PRP composites could enhance the regeneration of AC defects 11 and that PRP, in a poly-lactic-glycolic acid scaffold, could improve osteochondral healing in a rabbit model 12 .
Our group has investigated the therapeutic potential of muscle derived stem cells (MDSCs) for the treatment of various diseases and conditions of the musculoskeletal system because of their ability to undergo multilineage differentiation 13e19 . More importantly for the current investigation, we have reported that MDSCs can undergo chondrogenesis in vivo and in vitro 20, 21 , and that bone morphogenetic protein 4 (BMP-4)-transduced MDSCs could improve AC regeneration after injury 22 . Moreover, we have shown that soluble Flt-1 (sFlt1; a vascular endothelial growth factor (VEGF) antagonist)/BMP-4 transduced MDSCs could enhance cartilage regeneration in rats with induced osteoarthritis (OA) when transplanted intra-articularly by blocking the intrinsic VEGF catabolic pathway and extrinsic VEGF-induced vascular invasion which prevents chondrocyte apoptosis 23 . These results taken together showed that blocking angiogenesis, combined with BMP-4 expressing MDSCs was effective for OA repair. Despite the fact that PRP contains many growth factors and cytokines that promote angiogenesis, PRP has been reported to have a positive effect on cartilage repair 9e12 . In the current study, we performed a set of experiments in a rat model of OA designed to investigate whether PRP could enhance the therapeutic effect that MDSCs have on OA injured AC, and also determined whether PRP could further increase the beneficial effects that retroviral constructs expressing sFlt1 and BMP-4 have on MDSC mediated AC repair during OA.
Materials and methods

Isolation of MDSCs and PRP preparation
MDSCs were isolated from the hind-limb skeletal muscle of C57-BL10J mice, (Jackson Laboratory, Bar Harbor, ME) via a modified preplate technique, and MDSCs were transduced separately with retroviral vectors encoding for green fluorescent protein (GFP), BMP-4 and GFP (B4eGFP) or sFlt1 and LacZ (sFlt1eLacZ) as previously described 23 . PRP was isolated from the whole blood of nude rats (NIH-Whn NIHRNU-M; Taconic, NY, USA) via a double centrifugation technique as previously described 24 .
Repair of MIA-induced arthritis
The animal experiments performed in this study were approved by the Institutional Animal Care and Use Committee at University of Pittsburgh. Thirty-six female nude rats (NIH-Whn NIHRNU-M; Taconic) were used in this study. The animals were anesthetized with 3% isofluorane in O 2 gas (1.5 L/min). OA-like arthritis was induced by a single intra-articular knee injection of monosodium iodoacetate (MIA) (Aldrich Chemical, Milwaukee, WI) (0.3 mg/150 mg body weight) into the bilateral knee joints of the rats. Two weeks after MIA injection, each group of rats had their knee joints treated as described in Table I . Rats were sacrificed 4 and 12 weeks after cell transplantation (n ¼ 6 OA knees from three rats in each treatment group for each time point) as previously described 23 .
Histological evaluation of cartilage repair
Serial sagittal sections, 5 mm in thickness, were cut and stained with Safranin Oefast green. We evaluated OA repair semiquantitatively using a grading and staging system 25 . In this system, there are six histological grades and four histological stages. The total score (score ¼ grade Â stage) ranging from 1 point (normal AC) to 24 points (no repair) was evaluated by three researchers blinded to the treatment groups.
Contribution of transduced MDSCs in the cartilage healing process
To detect transplanted mouse cells in the femoral condyle, immunohistochemistry was performed at week 4 with the following antibodies; rabbit anti-rat type 2 collagen (Col2) (Sigma) to detect rat and mouse chondrocytes 21 , rabbit anti-GFP Alexa Fluor 488 conjugated (Molecular Probe, Eugene, OR) for detection of B4eGFPeMDSCs and GFPeMDSCs, and biotin-conjugated anti-b-galactosidase (b-gal) for detection of sFlt1eLacZeMDSCs. The numbers of double-positive and Col2-positive cells were morphometrically counted in five randomly selected soft tissue fields in the femoral condyle by using Northern Eclipse software (Empix Imaging Inc., Cheektowaga, NY). The following secondary antibodies were used for each immunostaining: Alexa Fluor 594-conjugated donkey anti-rabbit IgG (Molecular Probes) was used for Col2 staining and Alexa Fluor 488-conjugated goat antimouse IgG (Molecular Probes) was used for GFP and b-gal staining.
Chondrocyte apoptosis analysis
TUNEL assay was performed on the 4-week time point groups using an Apop Tag Plus Peroxidase In Situ Apoptosis Detection Kit according to the manufacturer's instructions (CHEMICON, Temecula, CA). After the staining, the positive signals were examined by light microscopy (n ¼ 6 knees in each group).
Cell functional assays and mixed pellet culture
To assess the effects of PRP, BMP-4 and sFlt1 on cell function of MDSCs including proliferation, adhesion and migration, each assay was performed and the detailed methods and the treatment groups in these assays are shown in Supplementary Information. Pellet cultures were also performed with the mixed-cell components. 
Statistical analysis
All values were expressed as 95% confidence intervals (95% CI). Comparisons among multiple groups were made using analysis of 
Results
Platelet count
The platelets found in the PRP used in these studies exhibited normal morphology. Platelet counts revealed that the PRP preparation technique produced highly concentrated platelet containing plasma. PRP smears showed higher concentrations of platelets than whole blood ones. The average whole blood platelet count was 42 ) which is a 5.5-fold increase in platelets.
Effect of PRP on MDSC mediated AC repair (macroscopic and histological evaluation of the femoral condyles)
There was no gross evidence of any side effects from the retroviral transduction such as a reduction in proliferation, changes in the cell differentiation behavior, nor in their neoplastic transformation behavior throughout the observation period. Twelve weeks after transplantation in the M þ PRP group, the AC surfaces appeared to be smooth though osteophyte formation was more advanced than at the 4-week time point. On the other hand, the M, PRP, and PBS groups all showed a marked progression of arthritis. Histologic assessment also demonstrated destructive events including pannus invasion, osteolysis, cyst formation within the subchondral bone area, and reduction in Safranin O-positive staining in the PRP and PBS groups. A histological grading scale 25 was used to evaluate the quality of the repaired tissues. At 4 weeks following transplantation, the total score of the M þ PRP group was significantly better than the PRP and PBS groups [P ¼ 0.0470 for M þ PRP vs PRP group; P ¼ 0.0330 for M þ PRP vs PBS group (Note that the lower the score the better the cartilage repair)] [ Fig. 1(C) ]. Twelve weeks following transplantation, the total score of the M þ PRP group was still significantly better than the PRP and PBS groups (P ¼ 0.0340 for M þ PRP vs PRP group; P ¼ 0.0060 for M þ PRP vs PBS group) [ Fig. 1(C) ]. There were no significant differences between the M þ PRP and M groups at 4 and 12 weeks after transplantation (week 4, P ¼ 0.1860; week 12, P ¼ 0.2520). 
MDSCs contribution to the AC repair process
Chondrocyte apoptosis analyses
Chondrocyte apoptosis was less abundant in the superficial/mid zone of the femoral condyles in the M þ PRP group when compared with the PRP and PBS groups [ Fig. 2(D) ]. Quantification of the Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) stained cells showed that the M þ PRP group showed significantly fewer apoptotic chondrocytes compared to the PRP and PBS groups (P ¼ 0.0050 for M þ PRP vs PRP; P ¼ 0.0020 for M þ PRP vs PBS), however, there was no significant difference between the M þ PRP and M groups (P ¼ 0.0790) [ Fig. 2(E) ].
Beneficial effect of PRP on BMP-4 and sFlt1 expressing MDSC therapy
In the current study, PRP provided only a limited effect on the regenerative potential of MDSCs toward cartilage repair after OA ( Figs. 1 and 2 ), when compared with our previous paper which used transduced MDSCs 23 . As PRP contains angiogenic factors that can have deleterious effects on the AC repair process, and BMP-4 has been found to be important for MDSC mediated AC repair, we performed additional experiments using PRP and MDSCs that expressed both BMP-4 and sFlt1.
MDSCs (M) were retrovirally transduced with sFlt1eLacZ (sFlt1) or BMP-4eGFP (B4) and then combined at a 1:1 ratio prior to transplantation (MesFlt1/B4) ( Table I) . Four weeks after MDSC transplantation, macroscopic evaluation of the groups revealed smooth joint surfaces of AC and no osteophyte formation [ Fig. 3(A) ]. Histologic assessment demonstrated that more Safranin O-positive hyaline-like cartilage was present in the MesFlt1/B4 þ PRP and Me sFlt1/B4 groups when compared with the M þ PRP group [ Fig. 3(B) ]. Twelve weeks after transplantation, rat knees treated with MesFlt1/ B4 þ PRP or MesFlt1/B4 still showed smooth joint surfaces in most regions of the articular condyles [ Fig. 3(A) ]. Histologic assessment also demonstrated that more Safranin O-positive tissue and fewer clusters of chondrocytes present within necrotic-like-tissue were found in the MesFlt1/B4 þ PRP and MesFlt1/B4 groups when compared with the other groups shown in Fig. 1 [Fig. 3(B) ].
In the histological grading scale at week 4, the score of the MesFlt1/ B4 þ PRP group was significantly better than the MesFlt1/B4 group (P ¼ 0.0020) [ Fig. 3(C) ]. Twelve weeks following transplantation, there was no significant difference between the MesFlt1/B4 þ PRP and the MesFlt1/B4 groups (P ¼ 0.2640) [ Fig. 3(C) ]. Of note, the MesFlt1/ B4 þ PRP and MesFlt1/B4 groups maintained scores similar to the scores given at the 4-week time point.
Contributions of BMP-4 and sFlt1 expressing MDSCs to the AC repair process
Differentiated chondrocytes derived from transduced MDSCs were determined at week 4 by detecting cells double stained for positive cells than the MesFlt1/B4 group (P ¼ 0.0200) [Fig. 4(C) ], and the number of GFP/b-gal positive cells was significantly greater in the MesFlt1/B4 þ PRP group than the MesFlt1/B4 group (P ¼ 0.0220) [Fig. 4(D) ]. The total number of Col2-positive cells was significantly higher in the MesFlt1/B4 þ PRP group compared to the MesFlt1/B4 group (P ¼ 0.0180) [Fig. 4(E) ]. 
Chondrocyte apoptosis analyses in OA knees injected with BMP-4 and sFlt1 transduced MDSCs
Chondrocyte apoptosis was less abundant in the MesFlt1/ B4 þ PRP group [ Fig. 4(F) ]. Quantification of the TUNEL stained cells showed that there were significantly fewer apoptotic chondrocytes in the MesFlt1/B4 þ PRP group than in the MesFlt1/B4 group (P ¼ 0.0120) [Fig. 4(G) ].
Mixed pellet culture experiments
To assess the reciprocal effects between MDSCs and OA chondrocytes (OA-C) with/without PRP, we performed mixed-cell pellet culture experiments. As a control group, we set OA-C group which included OA chondrocytes alone, not mixed with MDSCs. All cell groups tested formed pellets. The pellets in the MeB4 þ PRP, MeB4 and MesFlt1 þ PRP groups were significantly larger than the Me sFlt1, M þ PRP, M and OA-C groups (P ¼ 0.0026 for MeB4 þ PRP vs M þ PRP; P < 0.001 for MeB4 þ PRP vs MesFlt1, M and OA-C; P ¼ 0.0108 for MeB4 vs M þ PRP; P ¼ 0.0027 for MeB4 vs MesFlt1; P < 0.001 for MeB4 vs M and OA-C; P ¼ 0.0140 for MesFlt1 þ PRP vs M þ PRP; P ¼ 0.0036 for MesFlt1 þ PRP vs MesFlt1; P < 0.001 for MesFlt1 þ PRP vs M and OA-C). The pellets in the MesFlt1 group were significantly larger than the M and OA-C groups. (P ¼ 0.0285 for MesFlt1 vs M; P < 0.001 for MesFlt1 vs OA-C) [ Fig. 5(A) ]. The pellets from every group showed hyaline cartilage-like extracellular matrix (ECM) that stained positively for Alcian blue and contained welldifferentiated, round chondrocyte-like cells [ Fig. 5(B) ].
To analyze the effect of PRP on chondrocyte apoptosis in cultured pellets, TUNEL staining was performed using pellet samples obtained 3 weeks after cultivation. Chondrocyte apoptosis was less abundant in the MesFlt1 þ PRP and MesFlt1 groups [ Fig. 5(B) ]. Quantification of the TUNEL stained cells showed that the Me sFlt1 þ PRP and MesFlt1 groups showed fewer apoptotic cells compared with the other treatment groups (P < 0.001 for Me sFlt1 þ PRP vs MeB4 þ PRP; P ¼ 0.0018 for MesFlt1 þ PRP vs MeB4; P ¼ 0.0021 for MesFlt1 þ PRP vs M þ PRP; P ¼ 0.0452 for Me sFlt1 þ PRP vs M; P ¼ 0.0110 for MesFlt1 þ PRP vs OA-C; P < 0.001 for MesFlt1 vs MeB4 þ PRP, MeB4, M þ PRP and OA-C; P ¼ 0.0170 for MesFlt1 vs M). The number of apoptotic cells was significantly higher in the MeB4 þ PRP group than the MeB4 group, as well as in the M þ PRP group than the M groups (P ¼ 0.0072 for MeB4 þ PRP vs MeB4; P ¼ 0.0448 for M þ PRP vs M); however, there was no significant difference between the MesFlt1 þ PRP and Me sFlt1 groups (P ¼ 0.3874 for MesFlt1 þ PRP vs MesFlt1) [ Fig. 5(C) ].
Immunohistochemical staining for Col2 showed that collagen synthesis within the pellets was enhanced in the MeB4 þ PRP and MeB4 groups [ Fig. 5(B) ]. Quantitative analysis revealed that there was no significant difference between the MeB4 þ PRP and MeB4 groups, as well as between the M þ PRP and M groups (P ¼ 0.2246 for MeB4 þ PRP vs MeB4; P ¼ 0.1538 for M þ PRP vs M); however, the number of Col2-positive cells was significantly higher in the MesFlt1 þ PRP group than the MesFlt1 group (P ¼ 0.0315 for Me sFlt1 þ PRP vs MesFlt1) [ Fig. 5(D) ].
Discussion
In the present study, we initially determined whether PRP can improve the beneficial effect imparted by MDSCs for AC repair after OA induction by comparing the regenerative potential of MDSCs þ PRP treatment with the MDSCs alone. Although B4 groups showed significantly fewer apoptotic chondrocytes compared to the other treatment groups. The number of apoptotic chondrocytes was significantly fewer in the Me sFlt1/B4 þ PRP group than the MesFlt1/B4 group (n ¼ 6 knees in each group). a significant increase in the number of Col2-positive cells was observed in the M þ PRP group when compared to the M alone group, no significant difference was noted between these two groups in the histological assessment of AC repair and cell apoptosis analysis (Figs. 1 and 2) . These results suggest that PRP provided only a limited effect on the regenerative potential of MDSCs in cartilage repair after OA induction. Since PRP contains angiogenic factors that can have deleterious effects on the AC repair process, and BMP-4 has been found important for MDSC mediated AC repair, we performed additional experiments where sFlt1 (an angiogenic antagonist) and BMP-4 were added to the PRP and MDSCs. Our results indicate that the combination of PRP and BMP-4/sFlt1 expressing MDSCs results in a significantly better beneficial effect on AC repair when compared to all the other groups tested; however, the beneficial effect that PRP has on MDSCs expressing BMP-4 and sFlt1 appears to be transient since the histological assessment of AC repair was found to not be significantly different than the BMP-4 and sFlt1 expressing MDSCs at 12 weeks posttransplantation. From these results, we concluded that PRP could work more effectively for MDSC mediated cartilage repair when combined with BMP-4/sFlt1, and that the influence of PRP may not have lasted over the 12-week period of the experiment since the PRP was injected only once into knee capsule in this study.
Our study also revealed a lack of beneficial effects exhibited by the PRP group on AC repair at both 4 and 12 weeks after injection which is in contrast to prior manuscripts that reported PRP's effectiveness for cartilage repair 12, 26 ; however, in these studies the investigators administered PRP multiple times or via biodegradable scaffolds. Therefore, we believe that this disparity is related to the frequency of PRP administration and the use of a scaffold. Hence, continuous PRP administration should be considered an important influential factor for future clinical applications of PRP for AC repair.
In the in vivo apoptosis assay, chondrocyte apoptosis was significantly reduced in the M þ PRP group when compared with the PRP and PBS groups but there was no significant difference between the M þ PRP and the M groups (Fig. 2) . On the other hand, the MesFlt1/B4 þ PRP group showed a significant reduction in chondrocyte apoptosis compared with the MesFlt1/B4 group (Fig. 4) . In our previous study, we reported that VEGF induced higher levels of chondrocyte apoptosis in the OA knee than all the other groups and that sFlt1-treated OA knees showed the lowest level of chondrocyte apoptosis 23 . It has been reported that VEGF increases the catabolic pathway in AC tissue through the stimulation of Matrix metalloproteinases (MMP) activity and the reduction of tissue inhibitors of metalloproteinases (TIMPs), which consequently leads to cartilage destruction by enhancing angiogenesis and vascular invasion 23, 27, 28 . Taken together, we posited that the enhancement of chondrocyte apoptosis by PRP was suppressed by sFlt1 in the MesFlt1/B4 þ PRP group and believe this could represent a major mechanism of why PRP's effect is enhanced when used in combination with sFlt1 for AC repair. In order to clarify the interactions that PRP, BMP-4 and sFlt1 have on MDSC mediated AC repair, we performed in vitro studies to assay for cell proliferation, adhesion and migration, as well as with a pellet culture system. The results indicated that PRP induced higher levels of MDSC proliferation, adhesion and migration ( Supplementary  Fig. AeC) . These PRP related effects potentially enhanced the BMP-4/sFlt1 expressing MDSCs direct contribution to the cartilage repair process in our in vivo experiments. These results are in agreement with reports showing that PRP enhances cell proliferation and migration of bone marrow MSCs, adipose-derived stem cells, osteoblasts and chondrocytes 29e32 . Also, another paper reported that PRP could promote cell adhesion and migration of fibroblasts 33 . In the pellet culture assay, PRP þ sFlt1 had a significant effect on the size of the pellets formed, while PRP alone had no significant effect on the pellet size (Fig. 5) . On the other hand, the increased pellet size observed in our experiment may not be entirely related to chondrogenic differentiation of the MDSCs but could also represent an indirect effect that PRP had on cell proliferation and ECM production; therefore, the entire effect that PRP has on the chondrogenic potential of MDSCs is still unclear and further studies are required. This pellet culture assay also demonstrated that PRP had an effect that increased the number of apoptotic cells in the chondrocyte pellets, which in turn was reduced with the addition of sFlt1 (Fig. 5) . Interestingly, this finding was inconsistent with our in vivo results that showed that PRP did not promote cell apoptosis during cartilage repair. Recently, it was reported that PRP could affect synovial fibroblasts to increase hyaluronic acid production 36 and also promote chondrocytes to maintain their phenotype and to inhibit cellular de-differentiation 37 . In our in vivo study, PRP could have some effects, not only on the transplanted MDSCs, but also on the joint tissues including synovium, fat pad, bone marrow as well as the AC, which could potentially suppress the effects of PRP on chondrocyte apoptosis. Additional experiments are required to test the effectiveness of PRP on the healing of these other intra-articular structures.
We also revealed that PRP could promote collagen synthesis (Fig. 5) . Some growth factors included in PRP, such as TGF-b1, IGF-I, BMP-2 and -7, have already been reported to have an effect of promoting collagen synthesis 38, 39 , which supports our findings that PRP enhances collagen synthesis. This increase of collagen synthesis could represent another mechanism by which PRP enhances AC healing. Recently, PRP has been reported to be effective for the treatment of AC. Sanchez et al. showed the effectiveness of intra-articular injections of an autologous preparation rich in growth factors for the treatment of OA in the knee, in retrospective matched cohort study 40 . Furthermore, Kon et al. reported that the use of PRP injections was safe and had the potential to reduce pain and improve knee function and quality of life in younger patients with low degrees of AC degeneration 41 ; however, further studies are necessary to clarify the clinical application of PRP and to better understand its mechanism of action. For example, it has been shown that platelets could potentially be involved in the induction of arthritis 42 . Several limitations should be noted in this study. Firstly, we did not include a group that utilized MDSCs that expressed sFlt1 alone or with sFlt1 and PRP in our in vivo studies. Our previous studies have suggested that BMP-4 has a critical effect on MDSC therapy for cartilage repair; therefore we considered the addition of BMP-4 to be indispensable for this type of cell therapy to treat OA. To elucidate the mechanisms of this combined therapy, we performed in vitro studies using either BMP-4 or sFlt1 separately. The second limitation to our study was the fact that our OA model was chemically induced which is thought to be less clinically relevant than surgically induced OA models which better resemble the pathophysiology of OA; however, the reproducibility of the grade Quantification of the TUNEL stained cells showed that the MesFlt1 þ PRP and MesFlt1 groups showed fewer apoptotic cells compared with the other treatment groups, and that PRP increased TUNEL stained cells (n ¼ 3 in each group). (D) Quantitative analysis revealed that there is no significant difference between the MeB4 þ PRP and MeB4 groups, as well as between the M þ PRP and M groups. Whereas the number of Col2-positive cells was significantly higher in the MesFlt1 þ PRP group than the MesFlt1 group (n ¼ 3 in each group). and stage of OA achieved using the chemically induced model in immunodeficient rats was highly consistent with previous reports of OA in other rat strains 43, 44 . In this study, we used bilateral knees in a rat, accordingly we cannot exclude the possibility of an influence from the opposite treatment side of the animal. The third limitation to this study was the fact that the PRP used in this study was not characterized for its composition and physical characteristics. Besides variations between donors, there have been a variety of ways to isolate PRP reported; hence the composition of the PRPs isolated will differ from one another in composition. The advantage of PRP is its ready accessibility, simple preparation and that it is an autologously-derived material; however, standardized methods for isolating PRP are required.
In conclusion, our findings indicate that PRP can promote the therapeutic effect of MDSCs expressing BMP-4 and sFlt1 for chondral repair 4 weeks after transplantation via the promotion of collagen synthesis and the suppression of chondrocyte apoptosis; however, the PRP effects are only transient since at 12 weeks the beneficial effect of the PRP is lost.
